Skip to main content
. Author manuscript; available in PMC: 2017 Oct 15.
Published in final edited form as: Cancer. 2016 Aug 8;122(20):3127–3135. doi: 10.1002/cncr.30159

Table 2.

Presentation of disease by insurance status among men with germ cell or trophoblastic gonadal neoplasms, SEER database 2007–2011

Insured Any Medicaid Uninsured
RR RR
(95% CI)
p RR
(95% CI)
p
Metastatic disease at diagnosis (ref) 1.62
(1.51–1.74)
<0.001 1.26
(1.15–1.38)
<0.001
Intermediate or poor IGCCC category at diagnosis** (ref) 1.39
(1.23–1.57)
<0.001 1.22
(1.04–1.44)
0.01
Tumor size ≥4cm at diagnosis (ref) 1.32
(1.25–1.39)
<0.001 1.36
(1.29–1.43)
<0.001

Abbreviations: RR = relative risk; IGCCC = International germ cell consensus classification.

*

Multivariable model adjusted for age, income, education level, race/ethnicity, geographic region, year of diagnosis, urban/rural setting, and tumor histology.

**

Among men with metastatic disease